DD103559A5 - - Google Patents

Info

Publication number
DD103559A5
DD103559A5 DD169223A DD16922373A DD103559A5 DD 103559 A5 DD103559 A5 DD 103559A5 DD 169223 A DD169223 A DD 169223A DD 16922373 A DD16922373 A DD 16922373A DD 103559 A5 DD103559 A5 DD 103559A5
Authority
DD
German Democratic Republic
Application number
DD169223A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD103559A5 publication Critical patent/DD103559A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD169223A 1972-03-06 1973-03-05 DD103559A5 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00232294A US3833727A (en) 1972-03-06 1972-03-06 Hydralazine and beta-adrenergic blocking agent compositions for treating hypertension

Publications (1)

Publication Number Publication Date
DD103559A5 true DD103559A5 (cg-RX-API-DMAC10.html) 1974-02-05

Family

ID=22872572

Family Applications (1)

Application Number Title Priority Date Filing Date
DD169223A DD103559A5 (cg-RX-API-DMAC10.html) 1972-03-06 1973-03-05

Country Status (19)

Country Link
US (1) US3833727A (cg-RX-API-DMAC10.html)
AT (1) AT331966B (cg-RX-API-DMAC10.html)
BE (1) BE796288A (cg-RX-API-DMAC10.html)
CA (1) CA1015662A (cg-RX-API-DMAC10.html)
CY (1) CY951A (cg-RX-API-DMAC10.html)
DD (1) DD103559A5 (cg-RX-API-DMAC10.html)
FR (1) FR2181786B1 (cg-RX-API-DMAC10.html)
GB (1) GB1385648A (cg-RX-API-DMAC10.html)
HK (1) HK23378A (cg-RX-API-DMAC10.html)
HU (1) HU165714B (cg-RX-API-DMAC10.html)
IE (1) IE37326B1 (cg-RX-API-DMAC10.html)
IL (1) IL41610A (cg-RX-API-DMAC10.html)
KE (1) KE2839A (cg-RX-API-DMAC10.html)
LU (1) LU67144A1 (cg-RX-API-DMAC10.html)
MY (1) MY7800295A (cg-RX-API-DMAC10.html)
NL (1) NL176746C (cg-RX-API-DMAC10.html)
PH (1) PH18901A (cg-RX-API-DMAC10.html)
SE (1) SE400472B (cg-RX-API-DMAC10.html)
ZA (1) ZA731505B (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001421A (en) * 1971-10-27 1977-01-04 Syntex (U.S.A.) Inc. Thiazole cardiovascular agents
AU540656B2 (en) * 1980-02-19 1984-11-29 Merck & Co., Inc. S-(-)-1-(tert-butylamino-3((4-morpholino-1,2,5-thiadiazol-3- yl)-oxy)-2-propanol pamoate
US4521414A (en) * 1981-06-18 1985-06-04 The Texas A&M University System Ophthalmic compositions and their use for treating elevated intraocular pressure and glaucoma
US20110092507A1 (en) * 2009-10-20 2011-04-21 Chin-Tsai Fan Process for preparing R-(+)-3-morpholino-4-(3- tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole

Also Published As

Publication number Publication date
CY951A (en) 1978-12-22
PH18901A (en) 1985-10-30
HK23378A (en) 1978-05-12
GB1385648A (en) 1975-02-26
KE2839A (en) 1978-05-26
IL41610A (en) 1975-08-31
IE37326L (en) 1973-09-06
SE400472B (sv) 1978-04-03
BE796288A (fr) 1973-09-05
ZA731505B (en) 1974-10-30
DE2310836B2 (de) 1976-11-04
CA1015662A (en) 1977-08-16
FR2181786B1 (cg-RX-API-DMAC10.html) 1976-05-14
FR2181786A1 (cg-RX-API-DMAC10.html) 1973-12-07
HU165714B (cg-RX-API-DMAC10.html) 1974-10-28
NL176746C (nl) 1985-06-03
IL41610A0 (en) 1973-04-30
LU67144A1 (cg-RX-API-DMAC10.html) 1973-09-06
AU5266273A (en) 1974-08-29
AT331966B (de) 1976-09-10
DE2310836A1 (de) 1973-09-20
ATA195873A (de) 1975-12-15
NL7302728A (cg-RX-API-DMAC10.html) 1973-09-10
IE37326B1 (en) 1977-06-22
US3833727A (en) 1974-09-03
NL176746B (nl) 1985-01-02
MY7800295A (en) 1978-12-31

Similar Documents

Publication Publication Date Title
FR2181786A1 (cg-RX-API-DMAC10.html)
JPS4935101A (cg-RX-API-DMAC10.html)
CS151864B1 (cg-RX-API-DMAC10.html)
CS154550B1 (cg-RX-API-DMAC10.html)
CS155025B1 (cg-RX-API-DMAC10.html)
CS156587B1 (cg-RX-API-DMAC10.html)
CS161353B1 (cg-RX-API-DMAC10.html)
CS160339B1 (cg-RX-API-DMAC10.html)
CS159966B1 (cg-RX-API-DMAC10.html)
CS159548B1 (cg-RX-API-DMAC10.html)
CS159521B1 (cg-RX-API-DMAC10.html)
CS159086B1 (cg-RX-API-DMAC10.html)
CS158793B1 (cg-RX-API-DMAC10.html)
CH578356A5 (cg-RX-API-DMAC10.html)
CH585912A5 (cg-RX-API-DMAC10.html)
CH563783A5 (cg-RX-API-DMAC10.html)
CH565177A5 (cg-RX-API-DMAC10.html)
CH565954A5 (cg-RX-API-DMAC10.html)
CH566675A5 (cg-RX-API-DMAC10.html)
CH567423A5 (cg-RX-API-DMAC10.html)
CH573756A5 (cg-RX-API-DMAC10.html)
CH575348A5 (cg-RX-API-DMAC10.html)
CH577790A5 (cg-RX-API-DMAC10.html)
CH578042A5 (cg-RX-API-DMAC10.html)
CH1773873A4 (cg-RX-API-DMAC10.html)